Original language | English |
---|---|
Pages (from-to) | 982-984 |
Number of pages | 3 |
Journal | JAMA Internal Medicine |
Volume | 179 |
Issue number | 7 |
DOIs | |
Publication status | Published - Jul 2019 |
Funding
Funding/Support: This study was funded by a Harold Rogers Prescription Drug Monitoring Program grant awarded by the US Department of Justice, Office of Justice Programs, Bureau of Justice Assistance, aimed at improving prescription drug monitoring programs to prevent and reduce misuse and abuse of prescription drugs. The Maryland Department of Health, Behavioral Health Administration, was awarded the grant in partnership with the Center for Population Health Information Technology at the Johns Hopkins Bloomberg School of Public Health for data analyses and subject matter expertise and the Chesapeake Regional Information Systems for our Patients to link the data sets. Mss Krawczyk and Schneider were supported by T32 grant 5T32DA007292-25 from the National Institute on Drug Abuse. Funding/Support: This research was funded by grants from the National Health and Medical Research Council of Australia (APP1122332) and the Canadian Institutes of Health Research (CIHR PJT-153275).
ASJC Scopus subject areas
- Internal Medicine